Pulmonary hypertension: therapeutic targets within the serotonin system.

Abstract

Pulmonary arterial hypertension (PAH) is characterized by a sustained and progressive elevation in pulmonary arterial pressure and pulmonary vascular remodelling leading to right heart failure and death. Prognosis is poor and novel therapeutic approaches are needed. The serotonin hypothesis of PAH originated in the 1960s after an outbreak of the disease was… (More)
DOI: 10.1038/bjp.2008.241

Topics

Cite this paper

@article{Dempsie2008PulmonaryHT, title={Pulmonary hypertension: therapeutic targets within the serotonin system.}, author={Yvonne Dempsie and Michael Maclean}, journal={British journal of pharmacology}, year={2008}, volume={155 4}, pages={455-62} }